Novo Nordisk (NYSE:NVO) and Glooko said today they jointly launched the Cornerstones4Care mobile application designed to aid individuals in managing their diabetes. The C4C application integrates Novo Nordisk’s diabetes knowledge and personalized patient support with Glooko’s digital platform and data analytics, the companies said, and is the 1st jointly developed product from the pair, which announced […]
Glooko
Insulet, Mayo Clinic get in on Glooko’s $35m Series C round
Insulet (NSDQ:PODD) and Mayo Clinic were among the new investors to get in on a $35 million Series C round for Glooko and its diabetes management platform. The round was led by new investor Georgian Partners, joined by Insulet and Mayo Clinic and existing backers Medtronic, Samsung, Canaan Partners and Social Capital, Mountain View, Calif.-based Glooko said. The […]
ADA 2017 Roundup: J&J inks dev deal with Qualcomm, launches next-gen OneTouch Reveal app
Johnson & Johnson (NYSE:JNJ) is continuing to develop its diabetes offerings, with its LifeScan business partnering with Qualcomm Life to improve its OneTouch Verio Flex blood glucose meters and launching a next-gen version of its OneTouch Reveal mobile app. The company will be partnering with the Qualcomm subsidiary to streamline wireless data capture from LifeScan’s […]
Glooko, Dexcom ink pact for cloud data sharing
Glooko and Dexcom Inc. (NSDQ:DXCM) said today that they’ve inked a pact to deliver data from all of Dexcom’s continuous glucose monitors into Glooko’s platform. The companies agreed to share the Dexcom CGM data in 2015; the new cloud-based deal doesn’t require proactive connection to the Glooko database to effect the data transmission, they said. “With this […]
Glooko, Ascensia ink diabetes data integration deal
Asensia Diabetes Care and Glooko said today they inked a global technology partnership deal through which Glooko’s Diabetes data management platform will be integrated with Ascensia’s Contour Next One and Contour Plus One blood glucose monitors. The integration of the systems will allow direct access to blood glucose data through Glooko’s mobile application and clinic data […]
Glooko, Diasend ink merger deal, raise $8m
Diabetes device developers Glooko and Diasend said today that they completed a merger, with the combined companies operating under the Glooko moniker. The newly merged firms said their platforms operate in 4,000 diabetes clinics in 23 countries, covering more than 95% of diabetes devices used worldwide. “This is a big day for us – we are thrilled to come together […]
Medtronic touts ‘closed-loop’ insulin management system | American Diabetes Assn. 2016 Scientific Sessions
Medtronic touts ‘closed-loop’ insulin management system In its latest step on the quest to create an artificial pancreas, Medtronic (NYSE:MDT) said a pivotal trial showed that its hybrid “closed-loop” insulin management system proved safe and effective. The HCL system is designed to automatically control blood glucose levels with minimal input or supervision from patients or […]
Diabetes: Insulet launches Glooko-linked data management system
Insulet (NSDQ:PODD) said yesterday that it’s launching a new data system for its OmniPod device that uses Glooko‘s diabetes management platform. Medtronic (NYSE:MDT)-backed Glooko’s platform is designed to integrate data from blood glucose monitors and other devices with either an Apple (NSDQ:AAPL) iPhone or Google (NSDQ:GOOG) Android application. Food intake, medication and insulin dosage can also be recorded to provide context for changes in […]
Diabetes: Medtronic partners with Samsung, Glooko; wins 510(k) for MiniMed Connect
Medtronic (NYSE:MDT) today announced a slew of developments from its diabetes treatment arm, including FDA clearance of its MiniMed Connect diabetes monitoring system; a partnership with Samsung Electronics (LON:BC94) to develop technology for diabetes management; and an agreement with diabetes-monitoring platform developer Glooko. The announcements were made at the American Diabetes Assn.’s annual meeting in Boston. […]
Diabetes: Glooko adds Dexcom, Insulet to platform
Glooko said yesterday that it inked deals with Dexcom (NSDQ:DXCM) and Insulet (NSDQ:PODD) to supply device data from both companies to its diabetes management platform. Glooko’s platform will now integrate Dexcom’s continuous glucose monitoring systems and Insulet’s OmniPod insulin management systems in a new version of the platform that’s slated for a summer release, the Palo Alto, Calif.-based company […]